Nyrada Inc (ASX:NYR)
Share Pricing & News Healthcare

AUD 0.125

0 (0%)
(As on 2022-12-08 20:56:56 AEDT)
Previous Close Open Close*
0.125 0.125 0.125
Market Cap Dividend Yield (Annualized)
AUD 19.501M 0.00%

Day Range
0.125L 0.125 H
52 WEEK HIGH LOW
0.1L 0.24 H

Chart Price & Information

Last Trade 0.125
Change% 0.0000
52 W H/L 0.240/0.100
EBITDA -3.954M
NPAT After Abnormal Items -3.96M
Equity 11.499M
ROE% -34.44%
Total Liabilities 515,478
Total Revenue 1.094M
Cash and Cash Equivalents 10.816M

Stock Information

Share price 0.125
Market Cap 19.501M
Price/Gross Cash Flow -7.59
Dividend Yield Excluding Special 0.00%
Ending Shares 156.009M
52-Week Range 0.240-0.100
Gross DPS (AUD) 0
Gross Dividend Yield (Annualized) 0.00%
Earnings Yield 0.000
Net Tangible Asset (NTA) 0.07
P/E ratio 0.000
Sector P/E --
EPS -2.54
EV/EBITDA --
Net Profit Margin (%) --
Gross Cash Flows Per Share -0.02
Net Gearing -94.06%
Sales Per Share 0.00
Book Value Per Share 0.07

Similar Companies

Related Articles

About Company

The U.S registered Nyrada Inc. (ASX:NYR) is a preclinical stage, drug development company that prominently focusses on advancing the non-oncology asset development. Founded in 2017, Nyrada got listed on Australian Securities Exchange on 16 January 2020. The biotechnology company specialises in novel small molecule drug development targeted for cardiovascular, neurodegenerative and chronic inflammatory diseases.

Corporate Information


Suite 3, Level 4, 828 Pacific Highway, GORDON, NSW, AUSTRALIA, 2072

Phone:+61 2 9053 1990

Website:http://www.nyrada.com/site/content/

Dividends

Ex-Date Net Dividend Frank Flag Period End Date Type Payable

Event Calendar

Event Type Event Date Event Year
Report (Annual) 2023-08-28 2023
Report (Prelim) 2023-08-28 2023
Report (Interim) 2023-02-24 2023